URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Thomas Watson

Concepts (215)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Esophageal Neoplasms
17
2004
133
4.720
Why?
Esophageal Diseases
7
1997
31
3.130
Why?
Esophagectomy
14
1997
66
2.770
Why?
Adenocarcinoma
11
2007
483
2.740
Why?
Esophagoscopy
9
2005
57
2.670
Why?
Barrett Esophagus
9
2004
79
2.650
Why?
Precancerous Conditions
3
2008
45
1.970
Why?
Gastroesophageal Reflux
6
1998
102
1.570
Why?
Esophagus
9
2007
119
1.410
Why?
Digestive System Surgical Procedures
2
2009
24
1.350
Why?
Lymph Nodes
3
2002
215
0.930
Why?
Trachea
2
2005
70
0.870
Why?
Fundoplication
3
2005
46
0.860
Why?
Mediastinum
2
2009
20
0.810
Why?
Bronchoscopy
1
2010
30
0.760
Why?
Stomach
5
1997
80
0.760
Why?
Deglutition
2
2009
17
0.740
Why?
Hernia, Hiatal
4
2009
27
0.700
Why?
Neoplasm Recurrence, Local
2
2008
295
0.700
Why?
Catheter Ablation
2
2009
81
0.690
Why?
Humans
47
1996
37165
0.690
Why?
Treatment Outcome
13
1996
2671
0.650
Why?
Robotics
1
2008
77
0.590
Why?
Homeodomain Proteins
4
2007
111
0.590
Why?
Manometry
4
2005
41
0.560
Why?
Patient Selection
6
1996
223
0.560
Why?
Esophagogastric Junction
1
2005
31
0.530
Why?
Polymethyl Methacrylate
1
2005
21
0.530
Why?
Lung Neoplasms
5
2002
435
0.530
Why?
Lung
2
1996
1148
0.500
Why?
Thoracic Surgery
1
2004
15
0.500
Why?
Hydrogen-Ion Concentration
2
2005
611
0.500
Why?
Preoperative Care
1
2005
137
0.490
Why?
Male
32
1998
20139
0.480
Why?
Bile Acids and Salts
3
2007
30
0.480
Why?
Lymphatic Metastasis
6
2002
153
0.440
Why?
Female
27
1998
20222
0.400
Why?
Jejunum
2
1997
54
0.400
Why?
Sensitivity and Specificity
4
2002
914
0.390
Why?
Aged
21
1998
7392
0.390
Why?
Colon
2
1997
77
0.390
Why?
Esophageal pH Monitoring
2
2009
4
0.380
Why?
Middle Aged
22
1998
10013
0.360
Why?
Surgical Procedures, Minimally Invasive
2
2008
33
0.360
Why?
Diagnostic Techniques, Digestive System
2
2009
6
0.350
Why?
Neoplasm Staging
6
2008
354
0.350
Why?
Radiation-Sensitizing Agents
2
2007
74
0.340
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
70
0.330
Why?
Follow-Up Studies
6
1998
1889
0.320
Why?
Risk Assessment
3
2005
875
0.310
Why?
Mucins
2
2007
30
0.300
Why?
Reconstructive Surgical Procedures
1
1998
93
0.300
Why?
Prognosis
3
2008
1078
0.290
Why?
Lung Transplantation
1
1996
12
0.290
Why?
Intestines
2
2007
153
0.280
Why?
Aged, 80 and over
11
2002
2588
0.280
Why?
Anastomosis, Surgical
3
1998
70
0.280
Why?
Peristalsis
2
2011
9
0.260
Why?
Bronchi
2
1996
86
0.260
Why?
Clinical Trials as Topic
2
2008
685
0.250
Why?
Survival Analysis
4
2008
589
0.250
Why?
Neoplasm Invasiveness
3
2009
160
0.240
Why?
Deglutition Disorders
2
1998
28
0.240
Why?
Predictive Value of Tests
3
2009
609
0.240
Why?
RNA, Messenger
4
2007
1893
0.230
Why?
Postoperative Complications
5
2007
764
0.230
Why?
Severity of Illness Index
3
2005
943
0.220
Why?
Emergencies
2
2009
83
0.220
Why?
Adult
14
1998
11572
0.220
Why?
Nucleosides
1
2012
11
0.220
Why?
Quantum Theory
1
2012
13
0.220
Why?
Deoxycholic Acid
2
2008
10
0.210
Why?
Population Surveillance
2
2009
144
0.210
Why?
Electric Impedance
1
2011
21
0.210
Why?
Tomography, X-Ray Computed
2
2002
785
0.200
Why?
Registries
2
2009
218
0.200
Why?
Esophageal Achalasia
1
2011
10
0.200
Why?
Retrospective Studies
6
1998
2302
0.200
Why?
Cancer Care Facilities
1
2010
12
0.190
Why?
Endoscopy
1
2011
87
0.190
Why?
Endosonography
1
2010
16
0.190
Why?
Taxoids
1
2010
13
0.190
Why?
Stents
1
2011
132
0.190
Why?
Length of Stay
2
2008
295
0.180
Why?
Surgical Procedures, Elective
1
2009
37
0.180
Why?
Lymph Node Excision
1
2010
54
0.180
Why?
Positron-Emission Tomography
1
2009
38
0.180
Why?
Carcinoma
1
2011
194
0.180
Why?
Kyphosis
1
2009
10
0.170
Why?
Swine
1
2009
182
0.170
Why?
Laparoscopy
1
2012
213
0.170
Why?
Patient Admission
1
2009
84
0.170
Why?
Blood Gas Monitoring, Transcutaneous
1
2009
10
0.170
Why?
Respiration Disorders
1
2009
7
0.170
Why?
Parathyroid Neoplasms
1
2009
12
0.170
Why?
Mediastinal Neoplasms
1
2009
21
0.170
Why?
Models, Animal
1
2009
140
0.170
Why?
Diffusion of Innovation
1
2008
24
0.170
Why?
Receptors, Notch
1
2009
66
0.170
Why?
Diagnosis, Differential
2
2004
889
0.160
Why?
Forecasting
1
2008
188
0.160
Why?
Prevalence
4
2009
582
0.160
Why?
Esophageal Stenosis
1
2007
18
0.160
Why?
Antineoplastic Agents, Phytogenic
1
2007
37
0.160
Why?
Receptor, Epidermal Growth Factor
1
2008
96
0.160
Why?
Anoxia
1
2009
159
0.160
Why?
Paclitaxel
1
2007
59
0.150
Why?
Biopsy, Needle
2
2003
149
0.150
Why?
Gastrectomy
1
2007
17
0.150
Why?
DNA
1
2012
862
0.150
Why?
Equipment Design
1
2008
253
0.150
Why?
Quality of Life
1
2011
528
0.140
Why?
Mediastinal Emphysema
1
2005
9
0.140
Why?
Epithelial Cells
1
2008
332
0.140
Why?
Injections, Intralesional
1
2005
14
0.140
Why?
Adolescent
5
1996
5044
0.130
Why?
Gastric Acidity Determination
1
2005
14
0.130
Why?
Incidence
1
2008
682
0.130
Why?
Pneumothorax
1
2004
23
0.130
Why?
Germinoma
1
2004
3
0.130
Why?
Wounds, Nonpenetrating
1
2005
70
0.130
Why?
Evaluation Studies as Topic
1
2005
247
0.130
Why?
Monitoring, Physiologic
1
2005
110
0.130
Why?
Young Adult
4
2009
1084
0.130
Why?
Hypertension, Pulmonary
1
2004
28
0.120
Why?
Mesothelioma
1
2004
28
0.120
Why?
Certification
1
2004
40
0.120
Why?
Pulmonary Emphysema
1
2004
34
0.120
Why?
Testicular Neoplasms
1
2004
55
0.120
Why?
Logistic Models
3
2010
626
0.120
Why?
Carcinoma, Squamous Cell
3
2009
238
0.110
Why?
Randomized Controlled Trials as Topic
1
2005
415
0.110
Why?
Tracheoesophageal Fistula
1
2002
6
0.110
Why?
Tracheostomy
1
2002
19
0.110
Why?
Surgical Flaps
1
2002
120
0.100
Why?
Signal Transduction
1
2009
1629
0.090
Why?
Kaplan-Meier Estimate
2
2010
207
0.090
Why?
Odds Ratio
2
2010
323
0.080
Why?
Endoscopy, Digestive System
1
1998
17
0.080
Why?
Child
2
1996
4342
0.080
Why?
Vagotomy
1
1997
11
0.080
Why?
Gene Expression Regulation
3
2007
895
0.080
Why?
Mucin-2
2
2007
7
0.080
Why?
Survival Rate
2
2009
619
0.080
Why?
Cell Line, Tumor
2
2009
576
0.080
Why?
Pneumonectomy
1
1996
14
0.070
Why?
Physical Fitness
1
1996
23
0.070
Why?
Cadaver
1
1996
88
0.070
Why?
Immunosuppression
1
1996
68
0.070
Why?
Tissue Donors
1
1996
70
0.070
Why?
Cystic Fibrosis
1
1996
63
0.070
Why?
New York
2
2009
1378
0.070
Why?
Graft Rejection
1
1996
144
0.070
Why?
Living Donors
1
1996
85
0.070
Why?
Tumor Cells, Cultured
2
2007
886
0.060
Why?
Reoperation
2
2002
190
0.060
Why?
Statistics, Nonparametric
2
2002
269
0.060
Why?
Clavicle
2
2002
19
0.060
Why?
Cell Line
2
2007
1623
0.050
Why?
Animals
1
2009
16416
0.050
Why?
Quality Improvement
1
2012
22
0.050
Why?
Neoplasm Grading
1
2011
9
0.050
Why?
Spasm
1
2011
8
0.050
Why?
Esophageal Sphincter, Lower
1
2011
5
0.050
Why?
Infant, Newborn
1
1996
1836
0.050
Why?
Cell Differentiation
2
2007
1127
0.050
Why?
Preoperative Period
1
2010
6
0.050
Why?
Tumor Stem Cell Assay
1
2010
24
0.050
Why?
SEER Program
1
2010
55
0.050
Why?
Dose Fractionation
1
2010
57
0.050
Why?
Vascular Neoplasms
1
2010
7
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2010
45
0.050
Why?
Remission Induction
1
2010
165
0.050
Why?
Prospective Studies
2
2002
1696
0.050
Why?
Mucous Membrane
1
2010
46
0.050
Why?
Translational Medical Research
1
2010
38
0.050
Why?
Cisplatin
1
2010
93
0.050
Why?
Dipeptides
1
2009
17
0.050
Why?
Databases, Factual
1
2010
159
0.040
Why?
Child, Preschool
1
1996
2737
0.040
Why?
Confidence Intervals
1
2010
164
0.040
Why?
Drug Administration Schedule
1
2010
374
0.040
Why?
Bone Diseases, Metabolic
1
2009
22
0.040
Why?
Hyperparathyroidism
1
2009
24
0.040
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2009
87
0.040
Why?
Pilot Projects
1
2010
446
0.040
Why?
Referral and Consultation
1
2010
207
0.040
Why?
Combined Modality Therapy
1
2010
491
0.040
Why?
Spinal Fractures
1
2009
36
0.040
Why?
World Health
1
2009
65
0.040
Why?
Cell Culture Techniques
1
2008
94
0.040
Why?
Sex Factors
1
2010
613
0.040
Why?
Photochemotherapy
1
2009
112
0.040
Why?
Biopsy
1
2009
384
0.040
Why?
Reference Values
1
2009
453
0.040
Why?
Lymphocytes
1
2009
298
0.040
Why?
Recombinant Proteins
1
2010
770
0.040
Why?
Ligands
1
2008
294
0.040
Why?
Analysis of Variance
1
2010
749
0.040
Why?
Cohort Studies
1
2011
984
0.040
Why?
Anastomosis, Roux-en-Y
1
2007
13
0.040
Why?
Catheterization
1
2007
124
0.040
Why?
Transcriptional Activation
1
2008
288
0.040
Why?
Treatment Failure
1
2007
131
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
436
0.030
Why?
Chi-Square Distribution
1
2007
347
0.030
Why?
Reproducibility of Results
1
2009
903
0.030
Why?
Phosphorylation
1
2008
839
0.030
Why?
Immunohistochemistry
1
2009
1082
0.030
Why?
Thoracostomy
1
2004
3
0.030
Why?
Pulmonary Artery
1
2004
82
0.030
Why?
United States
1
2010
2847
0.030
Why?
Risk Factors
1
2009
2331
0.030
Why?
Respiratory Distress Syndrome, Adult
1
2002
75
0.030
Why?
Respiration, Artificial
1
2002
176
0.020
Why?

Visualizations


Watson's Networks

Same Department